(Q37892625)

24 August 2017

1 reference

title

Extracellular matrix in angiogenesis: dynamic structures with translational potential (English)

1 reference

24 August 2017

0 references

1 reference

2

Jeffrey A Hubbell

1 reference

24 August 2017

Sabine A Eming

1

1 reference

24 August 2017

publication date

1 July 2011

1 reference

24 August 2017

published in

Experimental Dermatology

1 reference

24 August 2017

volume

20

1 reference

24 August 2017

issue

7

1 reference

24 August 2017

page(s)

605-613

1 reference

Angiogenesis in life, disease and medicine

24 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2011.01309.X

Zebrafish and Xenopus tadpoles: small animal models to study angiogenesis and lymphangiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2011.01309.X

The extracellular matrix in development and morphogenesis: a dynamic view

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2011.01309.X

Compensation by fibroblast growth factor 1 (FGF1) does not account for the mild phenotypic defects observed in FGF2 null mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2011.01309.X

VEGF receptor signalling - in control of vascular function

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2011.01309.X

Vascular endothelial growth factor: basic science and clinical progress

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2011.01309.X

Anti-vascular endothelial growth factor receptor-2 (Flk-1/KDR) antibody suppresses contact hypersensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2011.01309.X

Modes of resistance to anti-angiogenic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2011.01309.X

Development of ranibizumab, an anti-vascular endothelial growth factor antigen binding fragment, as therapy for neovascular age-related macular degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2011.01309.X

VEGF guides angiogenic sprouting utilizing endothelial tip cell filopodia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2011.01309.X

Dll4 signalling through Notch1 regulates formation of tip cells during angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2011.01309.X

Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2011.01309.X

Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2011.01309.X

Identification of vascular endothelial growth factor determinants for binding KDR and FLT-1 receptors. Generation of receptor-selective VEGF variants by site-directed mutagenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2011.01309.X

The vascular endothelial growth factor (VEGF) isoforms: differential deposition into the subepithelial extracellular matrix and bioactivity of extracellular matrix-bound VEGF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2011.01309.X

Impaired myocardial angiogenesis and ischemic cardiomyopathy in mice lacking the vascular endothelial growth factor isoforms VEGF164 and VEGF188

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2011.01309.X

Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2011.01309.X

Conditional switching of VEGF provides new insights into adult neovascularization and pro-angiogenic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2011.01309.X

Spatially restricted patterning cues provided by heparin-binding VEGF-A control blood vessel branching morphogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2011.01309.X

Transcriptional regulation of the Vascular Endothelial Growth Factor gene--a concert of activating factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2011.01309.X

The carboxyl-terminal domain (111-165) of vascular endothelial growth factor is critical for its mitogenic potency

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2011.01309.X

Extracellular cleavage of the vascular endothelial growth factor 189-amino acid form by urokinase is required for its mitogenic effect.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2011.01309.X

Proteolytic processing regulates receptor specificity and activity of VEGF-C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2011.01309.X

Plasmin activates the lymphangiogenic growth factors VEGF-C and VEGF-D

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2011.01309.X

Generation of a novel proteolysis resistant vascular endothelial growth factor165 variant by a site-directed mutation at the plasmin sensitive cleavage site.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2011.01309.X

Expression of vascular permeability factor (vascular endothelial growth factor) by epidermal keratinocytes during wound healing

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2011.01309.X

Topical vascular endothelial growth factor accelerates diabetic wound healing through increased angiogenesis and by mobilizing and recruiting bone marrow-derived cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2011.01309.X

Plasmin modulates vascular endothelial growth factor-A-mediated angiogenesis during wound repair

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2011.01309.X

Loss of vascular endothelial growth factor a activity in murine epidermal keratinocytes delays wound healing and inhibits tumor formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2011.01309.X

A wound size-dependent effect of myeloid cell-derived vascular endothelial growth factor on wound healing

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2011.01309.X

Adverse effects of anticancer agents that target the VEGF pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2011.01309.X

The extracellular matrix: not just pretty fibrils

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2011.01309.X

What mouse mutants teach us about extracellular matrix function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2011.01309.X

Expression and function of laminins in the embryonic and mature vasculature.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2011.01309.X

Loss of collagen XVIII enhances neovascularization and vascular permeability in atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2011.01309.X

Making the cut: protease-mediated regulation of angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2011.01309.X

Interaction of endostatin with integrins implicated in angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2011.01309.X

Interactions between extracellular matrix and growth factors in wound healing

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2011.01309.X

Integrins and angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2011.01309.X

Integrin alpha v beta 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2011.01309.X

A Bit-role for integrins in apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2011.01309.X

Genetic and cell biological analysis of integrin outside-in signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2011.01309.X

Integrin and growth factor receptor crosstalk.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2011.01309.X

Role of alphavbeta3 integrin in the activation of vascular endothelial growth factor receptor-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2011.01309.X

Differential alphav integrin-mediated Ras-ERK signaling during two pathways of angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2011.01309.X

A reevaluation of integrins as regulators of angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2011.01309.X

Stimulation of tumor growth and angiogenesis by low concentrations of RGD-mimetic integrin inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2011.01309.X

Heparanase accelerates wound angiogenesis and wound healing in mouse and rat models.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2011.01309.X

Proteoglycans in health and disease: new concepts for heparanase function in tumor progression and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2011.01309.X

Losartan, an AT1 antagonist, prevents aortic aneurysm in a mouse model of Marfan syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2011.01309.X

Endothelial cells dynamically compete for the tip cell position during angiogenic sprouting

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2011.01309.X

Anchorage of VEGF to the extracellular matrix conveys differential signaling responses to endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2011.01309.X

Pericytes: cell biology and pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2011.01309.X

Endothelial-mural cell signaling in vascular development and angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2011.01309.X

Promotion of wound repair in old mice by local injection of macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2011.01309.X

Activated macrophages induce vascular proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2011.01309.X

Tissue macrophages act as cellular chaperones for vascular anastomosis downstream of VEGF-mediated endothelial tip cell induction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2011.01309.X

Gene transfer as a tool to induce therapeutic vascular growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2011.01309.X

Local rh-VEGF administration enhances skin flap survival more than other types of rh-VEGF administration: a clinical, morphological and immunohistochemical study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2011.01309.X

Granulocyte/macrophage colony-stimulating factor treatment of human chronic ulcers promotes angiogenesis associated with de novo vascular endothelial growth factor transcription in the ulcer bed.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2011.01309.X

In vitro and in vivo activation of endothelial cells by colony-stimulating factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2011.01309.X

Processing of VEGF-A by matrix metalloproteinases regulates bioavailability and vascular patterning in tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2011.01309.X

Cell-demanded liberation of VEGF121 from fibrin implants induces local and controlled blood vessel growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2011.01309.X

Endothelial cell proliferation and progenitor maturation by fibrin-bound VEGF variants with differential susceptibilities to local cellular activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2011.01309.X

Synthetic biomaterials as instructive extracellular microenvironments for morphogenesis in tissue engineering.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2011.01309.X

Regenerative medicine in dermatology: biomaterials, tissue engineering, stem cells, gene transfer and beyond

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2011.01309.X

Matrices and scaffolds for protein delivery in tissue engineering

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2011.01309.X

A single autophosphorylation site on KDR/Flk-1 is essential for VEGF-A-dependent activation of PLC-gamma and DNA synthesis in vascular endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2011.01309.X

Identification of tyrosine residues in vascular endothelial growth factor receptor-2/FLK-1 involved in activation of phosphatidylinositol 3-kinase and cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2011.01309.X

Akt mediates cytoprotection of endothelial cells by vascular endothelial growth factor in an anchorage-dependent manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2011.01309.X

VEGF activates protein kinase C-dependent, but Ras-independent Raf-MEK-MAP kinase pathway for DNA synthesis in primary endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2011.01309.X

The RGD motif in fibronectin is essential for development but dispensable for fibril assembly

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2011.01309.X

A targeted mutation at the known collagenase cleavage site in mouse type I collagen impairs tissue remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2011.01309.X

Embryonic lethal mutation in mouse collagen I gene causes rupture of blood vessels and is associated with erythropoietic and mesenchymal cell death.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2011.01309.X

Type III collagen is crucial for collagen I fibrillogenesis and for normal cardiovascular development

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2011.01309.X

Mutations in Col4a1 cause perinatal cerebral hemorrhage and porencephaly.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2011.01309.X

Lack of type XV collagen causes a skeletal myopathy and cardiovascular defects in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2011.01309.X

Lack of collagen XVIII/endostatin results in eye abnormalities

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2011.01309.X

Elastin is an essential determinant of arterial morphogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2011.01309.X

EMILIN-1 deficiency induces elastogenesis and vascular cell defects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2011.01309.X

Targetting of the gene encoding fibrillin-1 recapitulates the vascular aspect of Marfan syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2011.01309.X

Perinatal lethality and endothelial cell abnormalities in several vessel compartments of fibulin-1-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2011.01309.X

Targeted disruption of fibulin-4 abolishes elastogenesis and causes perinatal lethality in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2011.01309.X

Fibulin-5 is an elastin-binding protein essential for elastic fibre development in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2011.01309.X

Fibulin-5/DANCE is essential for elastogenesis in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2011.01309.X

Deletion of the laminin alpha4 chain leads to impaired microvessel maturation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2011.01309.X

Roles for laminin in embryogenesis: exencephaly, syndactyly, and placentopathy in mice lacking the laminin alpha5 chain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2011.01309.X

Perlecan maintains the integrity of cartilage and some basement membranes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2011.01309.X

Thrombospondin-1 is a major activator of TGF-beta1 in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2011.01309.X

Roles of thrombospondin-1 and -2 in regulating corneal and iris angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2011.01309.X

The lack of thrombospondin-1 (TSP1) dictates the course of wound healing in double-TSP1/TSP2-null mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2011.01309.X

Accelerated wound healing in mice with a disruption of the thrombospondin 2 gene.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2011.01309.X

CYR61 (CCN1) is essential for placental development and vascular integrity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2011.01309.X

Connective tissue growth factor coordinates chondrogenesis and angiogenesis during skeletal development

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2011.01309.X

Vascular Endothelial Growth Factor Induction of the Angiogenic Phenotype Requires Ras Activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2011.01309.X

10.1111/J.1600-0625.2011.01309.X

21 January 2018

Identifiers

DOI

1 reference

24 August 2017

1 reference